Results 11 to 20 of about 3,317,094 (282)

Staphylococcal Infections: Host and Pathogenic Factors [PDF]

Microorganisms, 2021
In 1880, the Scottish surgeon Sir Alexander Ogston first described staphylococci in pus from a surgical abscess in a knee joint: “The masses looked like bunches of grapes” [...]
Rajan P. Adhikari
doaj   +2 more sources

Epidemiology of Staphylococcal Infections [PDF]

Anesthesia & Analgesia, 1960
During the period 1951–58, a study has been carried out of a series of seventeen families in which more than one member developed a staphylococcal lesion.In eleven of these families, phage typing revealed that spread of infection from person to person had occurred.
L. Roodyn
  +9 more sources

Repurposing ebselen for treatment of multidrug-resistant staphylococcal infections. [PDF]

Sci Rep, 2015
Novel antimicrobials and new approaches to developing them are urgently needed. Repurposing already-approved drugs with well-characterized toxicology and pharmacology is a novel way to reduce the time, cost and risk associated with antibiotic innovation.
Thangamani S, Younis W, Seleem MN.
europepmc   +2 more sources

Clinical Utility of Molecular Tests for Guiding Therapeutic Decisions in Bloodstream Staphylococcal Infections: A Meta-Analysis [PDF]

Frontiers in Pediatrics, 2021
Background: Treatment of bloodstream staphylococcal infections (BSI) necessitates the prompt initiation of appropriate antimicrobial agents and the rapid de-escalation of excessive broad-spectrum coverage to reduce the risk of mortality.
Ke Chen, Ke Chen, Aijaz Ahmad Malik, Yun-Jian Sheng, Yun-Jian Sheng, Sarfraz Ahmed, Changfeng Sun, Changfeng Sun, Cun-Liang Deng, Suvash Chandra Ojha, Suvash Chandra Ojha   +10 more
doaj   +2 more sources

Staphylococcal Infections And Urticaria:

Journal of Nepal Medical Association, 2003
NA
Katherine A Witherington
doaj   +3 more sources

Repurposing auranofin for the treatment of cutaneous staphylococcal infections. [PDF]

Int J Antimicrob Agents, 2016
Thangamani S, Mohammad H, Abushahba MF, Sobreira TJ, Seleem MN.   +4 more
europepmc   +2 more sources

Drug repurposing for the treatment of staphylococcal infections. [PDF]

Curr Pharm Des, 2015
Thangamani S, Mohammad H, Younis W, Seleem MN.   +3 more
europepmc   +2 more sources

Antimicrobial peptides and peptidomimetics - potent therapeutic allies for staphylococcal infections. [PDF]

Curr Pharm Des, 2015
Mohammad H, Thangamani S, Seleem MN.
europepmc   +2 more sources

Could Public Restrooms Be an Environment for Bacterial Resistomes? [PDF]

, 2013
PMCID: PMC3547874This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are ...
A Bizzini, A Fajardo, A Gardner, A Rahman, AA Vickers, BM Marshall, C Benagli, Charlotte A. Russell, CP Gerba, D Nathwani, E Carbonnelle, E Scott, EGA Fredheim, F Koksal, GD Wright, GD Wright, GE Flores, H Goto, Hermine V. Mkrtchyan, J Barker, J Karakulska, JY Park, K Fox, K Kummerer, L Nelson, M Cizman, M Kliem, M Nakib Al, MF Mendes, MN Alekshun, Nan Wang, Patrick M. Schlievert, PJ Turnbaugh, Ronald R. Cutler, S Bocher, S Miyakis, SB Levy, TL Overman, Y Katayama, Y Kondo, YW Miller   +40 more
core   +13 more sources

If, When, and How to Use Rifampin in Acute Staphylococcal Periprosthetic Joint Infections, a Multicentre Observational Study

Clinical Infectious Diseases, 2021
Background Rifampin is generally advised in the treatment of acute staphylococcal periprosthetic joint infections (PJI). However, if, when, and how to use rifampin remains a matter of debate.
M. Beldman, C. Löwik, Á. Soriano, Laila Albiach, W. Zijlstra, B. Knobben, P. Jutte, R. Sousa, A. Carvalho, K. Goswami, J. Parvizi, K. Belden, M. Wouthuyzen-Bakker   +12 more
semanticscholar   +1 more source